Intellia Therapeutics shares fell 25% amid safety concerns in Phase 3 trials. Check out if today's selloff in NTLA stock is a ...

TROPOS is a randomized, double-blind, placebo-controlled, global Phase 2 clinical trial to evaluate cibotercept in combination with background therapy in patients with PAH. On December 12, 2024, the ...

Welcome to your gateway to the IMF's global economic data. Our new data portal provides streamlined access to timely, reliable, and easy-to-understand macroeconomic and financial data. While the ...

Caregiver concern for clinical deterioration is associated with critical illness in paediatric patients and, after adjusting ...

A contested accident reconstruction expert testified Tuesday, explaining a series of experiments and measurements that he ...